HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High dose prednisolone treatment of leprosy patients undergoing reactions is associated with a rapid decrease in urinary nitric oxide metabolites and clinical improvement.

Abstract
Evidence is accumulating that nitric oxide (NO) produced by macrophages has a role in the pathogenesis of reactions in leprosy. We followed the urinary levels of the metabolites of NO [nitrite (NO2-) and nitrate (NO3-)] and the clinical response to prednisolone treatment in leprosy patients (n = 9) admitted to ALERT leprosy hospital Addis Ababa, Ethiopia, because of reversal reaction (RR) or erythema nodosum leprosum (ENL). In untreated reactional leprosy patients, the levels of urinary NO metabolites (1645 +/- 454 microM, n = 9, ENL = 4, RR = 5) decreased significantly 2 weeks after high dose prednisolone treatment (1075 +/- 414 microM, P < 0.05), and remained stable 4 (895 +/- 385 microM, P < 0.02) and 6 weeks following treatment initiation (1048 +/- 452 microM, P < 0.02). This decrease was also present when the reactional patients were subdivided according to the type of reaction (ENL, RR) and coincided with a clinical improvement. In patients showing a poor clinical response to steroids, no or minor effects on the urinary NO metabolite levels were observed. We conclude that there is a correlation between the decrease in urinary NO metabolites and a favourable clinical response after high dose prednisolone treatment of reactional leprosy patients.
AuthorsT Schön, R Leekassa, N Gebre, T Sundqvist, E Bizuneh, S Britton
JournalLeprosy review (Lepr Rev) Vol. 71 Issue 3 Pg. 355-62 (Sep 2000) ISSN: 0305-7518 [Print] England
PMID11105495 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Nitric Oxide
  • Prednisolone
Topics
  • Adolescent
  • Adult
  • Biomarkers (urine)
  • Dose-Response Relationship, Drug
  • Erythema Nodosum (drug therapy, urine)
  • Female
  • Humans
  • Leprosy (drug therapy, urine)
  • Leprosy, Borderline (drug therapy, urine)
  • Leprosy, Lepromatous (drug therapy, urine)
  • Male
  • Middle Aged
  • Nitric Oxide (metabolism, urine)
  • Prednisolone (administration & dosage)
  • Prognosis
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: